Caxton Associates (UK)’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$345K Buy
+4,726
New +$368K 0.01% 573
2025
Q3
Sell
-5,116
Closed -$430K 831
2025
Q2
$430K Sell
5,116
-1,066
-17% -$93.3K 0.01% 462
2025
Q1
$586K Buy
+6,182
New +$654K 0.02% 440

Other funds holding IOSP

Caxton Associates (UK)'s IOSP Position: Q1 2026 in Review

Caxton Associates (UK) opened a new position in Innospec (IOSP) in Q1 2026: 4,726 shares worth $345K. The stake represents 0.01% of the portfolio and ranks #573 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in IOSP as recently as Q2 2025.

Caxton Associates (UK) first reported a position in IOSP in Q1 2025 and has held it in 3 quarters since. The position peaked at $586K in Q1 2025. 266 funds tracked by Wall St. Rank hold IOSP as of Q1 2026.

  • Caxton Associates (UK) held 4,726 shares of Innospec worth $345K as of Q1 2026.
  • Innospec was a new Caxton Associates (UK) position in Q1 2026.
  • Innospec made up 0.01% of Caxton Associates (UK)'s portfolio in Q1 2026, its #573 holding.
  • Caxton Associates (UK) first reported a position in Innospec in Q1 2025 and has held it in 3 quarters since.
  • Caxton Associates (UK)'s Innospec position peaked at $586K in Q1 2025.
  • 266 funds tracked by Wall St. Rank held Innospec as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.